@madhukishwar focus your skills into writings focussing upon future actions, instead of debating history.
This is exactly what the vested interests want. i.e create further sub-divisions internally.
write about US vs st martin islands, cox-bazar china submarine, impacts in India, etc.
@Garyr9912@jimcramer@DrRogerNewton Thanks for this $ESPR link.
Did not know he was also the co- inventor of $PFE lipitor, the largest selling cholestrol drug.
@Pharmdca $EFTR
2 Gaming Visuals of PD-L1 in Tomi, for the uneducated like me, in what they are doing in this cancer fight.i.e PD-1(good) vs PD-L1 (bad), whose mkt is worth $4-5B.
Match ends EOM followed by results.
https://t.co/Ga22gZbQCU
https://t.co/zXZYqWnDEQ
@ATLanalyst@JacobPlieth $EFTR
CEO interview (17:00 - 40:00 min) from IPO days.
Key points:
-Tomi , Might not need a ph3, if FDA says so. (38th min).
- PPS In Multiples from IPO pricing.
-PFE stake for a reason to avoud competition from middle men.
@Pharmdca
https://t.co/B3833MYFoP